Buck Institute perspective argues for longitudin
Author: Michael
Serotonin Anti-Aging Centers has awarded a five-l
Edelman’s ‘100-year life’ report suggests
The global oligonucleotide therapeutics market is
Harness Therapeutics has nominated HRN001 as a fi
Wellbeing International Foundation backs cell-fr
Sana’s early diabetes data suggest hypoimmune
Belgium’s long-time biotech backer is stepping
Weight-loss pills are reshaping the market, but
QuantalX Neuroscience leverages FDA De Novo clea